No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype.

MLA

Siemes, C., et al. “No Modification of the Beneficial Effect of NSAIDs on Colorectal Cancer by CYP2C9 Genotype.” The Netherlands Journal of Medicine, vol. 67, no. 4, Apr. 2009, pp. 134–41. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=19581657&authtype=sso&custid=ns315887.

APA

Siemes, C., Eijgelsheim, M., Dieleman, J. P., van Schaik, R. H. N., Uitterlinden, A. G., van Duijn, C. M., Hofman, A., Coebergh, J. W. W., Stricker, B. H. C., & Visser, L. E. (2009). No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype. The Netherlands Journal of Medicine, 67(4), 134–141.

Chicago

Siemes, C, M Eijgelsheim, J P Dieleman, R H N van Schaik, A G Uitterlinden, C M van Duijn, A Hofman, J W W Coebergh, B H Ch Stricker, and L E Visser. 2009. “No Modification of the Beneficial Effect of NSAIDs on Colorectal Cancer by CYP2C9 Genotype.” The Netherlands Journal of Medicine 67 (4): 134–41. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=19581657&authtype=sso&custid=ns315887.